<p><b>A.</b> Levels of CDA mRNA in pancreatic and lung carcinoma cell lines were evaluated by real-time PCR for Panc-1, MIAPaCa-2, BxPC-3, H322, H1299, and H441. Normalized δCt was calculated as 35-(CDA Ct-GAPDH Ct). <b>B. </b>Three pancreatic and three lung cancer cell lines were cultured with just gemcitabine (GEM) alone, or with GEM and 100 mM tetrahydrouridine (THU). IC50 was determined using a colorimetric assay as described in the experimental procedures. Values are means ±SD, and results are representative of 3 independent experiments.</p
Gemcitabine or 5-fluorouracil (5-FU) based treatments can be selected for pancreatic cancer. Equilib...
Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Hi...
AbstractBackground/aims: Current in vitro drug sensitivity tests have limitations and disadvantages....
Cytidine deaminase (CDA) is a determinant of in vivo gemcitabine elimination kinetics and cellular t...
Gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC) is attributed to cancer cell-intri...
Cytidine deaminase (CDA) is the major enzyme of gemcitabine inactivation. The aim of this study was ...
<p>(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...
Gemcitabine is an inhibitor of ribonucleotide reductase (RR) and DNA polymerization with promising a...
Because cytidine deaminase (CDA) is the key enzyme in gemcitabine metabolism, numerous studies have ...
<div><p>Purpose</p><p>Because cytidine deaminase (CDA) is the key enzyme in gemcitabine metabolism, ...
Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Hi...
<p>(<b>A</b>) miR-148a endogenous expression level was measured by qRT-PCR in several PDAC cell line...
<p>Small molecule inhibitors of the checkpoint proteins CHK1 and WEE1 are currently in clinical deve...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
Checkpoint kinase 1 (Chk1) inhibition sensitizes pancreatic cancer cells and tumors to gemcitabine. ...
Gemcitabine or 5-fluorouracil (5-FU) based treatments can be selected for pancreatic cancer. Equilib...
Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Hi...
AbstractBackground/aims: Current in vitro drug sensitivity tests have limitations and disadvantages....
Cytidine deaminase (CDA) is a determinant of in vivo gemcitabine elimination kinetics and cellular t...
Gemcitabine resistance in pancreatic ductal adenocarcinoma (PDAC) is attributed to cancer cell-intri...
Cytidine deaminase (CDA) is the major enzyme of gemcitabine inactivation. The aim of this study was ...
<p>(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...
Gemcitabine is an inhibitor of ribonucleotide reductase (RR) and DNA polymerization with promising a...
Because cytidine deaminase (CDA) is the key enzyme in gemcitabine metabolism, numerous studies have ...
<div><p>Purpose</p><p>Because cytidine deaminase (CDA) is the key enzyme in gemcitabine metabolism, ...
Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Hi...
<p>(<b>A</b>) miR-148a endogenous expression level was measured by qRT-PCR in several PDAC cell line...
<p>Small molecule inhibitors of the checkpoint proteins CHK1 and WEE1 are currently in clinical deve...
BACKGROUND: Gemcitabine is an analogue of deoxycytidine with activity against several solid tumors. ...
Checkpoint kinase 1 (Chk1) inhibition sensitizes pancreatic cancer cells and tumors to gemcitabine. ...
Gemcitabine or 5-fluorouracil (5-FU) based treatments can be selected for pancreatic cancer. Equilib...
Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Hi...
AbstractBackground/aims: Current in vitro drug sensitivity tests have limitations and disadvantages....